Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
0.7751
+0.0011 (0.14%)
Jun 29, 2026, 2:16 PM EDT - Market open
Aptorum Group Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
6.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 431.38K | -864.51K | -66.71% |
| Dec 31, 2022 | 1.30M | -245.89K | -15.95% |
| Dec 31, 2021 | 1.54M | 630.27K | 69.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioAtla | 2.00M |
| Can-Fite BioPharma | 405.00K |
| Addex Therapeutics | 136.51K |
| Silo Pharma | 72.10K |
| Cardio Diagnostics Holdings | 16.57K |
| Pulmatrix | 3.00K |
| Soligenix | 2.34K |
APM News
- 7 days ago - Aptorum Group announces collaboration between DiamiR, AlzLabs - TheFly
- 7 days ago - Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer's Disease Biomarkers - GlobeNewsWire
- 10 days ago - Statement in Response to Silver Elephant's News Release Dated June 17, 2026 - Newsfile Corp
- 19 days ago - Aptorum Group shareholders approve merger with DiamiR Biosciences - TheFly
- 19 days ago - Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences - GlobeNewsWire
- 3 months ago - Aptorum Group, DiamiR announce publication of microRNA biomarker study - TheFly
- 3 months ago - Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania - GlobeNewsWire
- 4 months ago - Aptorum Group receives noncompliance notification from Nasdaq - TheFly